From Coronavirus Disease 2019 to Herpes Simplex Virus Hepatitis: A Case Report of Complications Linked to Immunosuppressive Therapy.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been linked to severe pneumonia and systemic deterioration in humans. When antiviral drugs and antibodies are not available, it is preferable to choose early treatment methods to suppress cytokine storms. While an interleukin-6 receptor antagonist has proven effective in controlling cytokine storms in coronavirus disease 2019 (COVID-19) pneumonia, it can also increase susceptibility to secondary infections, such as herpes simplex virus (HSV).